You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 11, November 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Dermatologic Disorders, Other
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Familial ACD With No Recognizable Enzyme Abnormalities

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the report by Kelly and Kelly1 of the case of a 33-year-old man with angiokeratoma corporis diffusum (ACD) with no recognizable enzyme abnormality.

In our practice, we saw 2 sisters, aged 26 and 31 years, who from puberty on developed numerous angiokeratomas in a typical bathing suit distribution (Figure). No other family member had ACD or a relevant clinical history. Histologic evaluation confirmed the diagnosis of angiokeratoma. The clinical distribution of these ACD lesions was that typically observed in X-linked Fabry disease. We therefore proceeded to do an extensive workup, including {alpha}-galactosidase, electron microscopic study of angiokeratoma specimens, urinary globotriaosylceramide determination, and sequencing of the exons of the {alpha}-galactosidase gene. Because the findings of these investigations were normal, we ruled out Fabry disease with 99% certainty (allowing a 1% margin of error because a partial deletion would not be detected with the {alpha}-galactosidase sequencing . . . [Full Text of this Article]


AUTHOR INFORMATION
Dan Lipsker, MD; Carine Kieffer, MD; Hamid Nojavan, MD; Bérénice Doray, MD; Bernard Cribier, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Angiokeratoma Corporis Diffusum in a Patient With No Recognizable Enzyme Abnormalities
Brent Kelly and Erica Kelly
Arch Dermatol. 2006;142(5):615-618.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.